Demethylzeylasteral Inhibits Lung Cancer Growth by Targeting LRPPRC
Author Information
Author(s): Wang Lina, Zhou Wei, Wang Wenxi, Liang Yuxin, Xue Qiqi, Zhang Zhen, Yuan Jinghe, Fang Xiaohong
Primary Institution: Key Laboratory of Molecular Nanostructure and Nanotechnology, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy of Science
Hypothesis
Can Demethylzeylasteral (T-96) inhibit the biogenesis of oxidative phosphorylation complexes in lung cancer by targeting LRPPRC?
Conclusion
Demethylzeylasteral effectively inhibits the growth of lung adenocarcinoma by targeting LRPPRC and disrupting oxidative phosphorylation complex biogenesis.
Supporting Evidence
- T-96 directly binds to LRPPRC, inhibiting its interaction with mt-mRNA.
- T-96 treatment significantly reduced the mRNA and protein levels of the OXPHOS complex.
- T-96 exhibited potent antitumor activity for lung adenocarcinoma in vitro and in vivo.
- The antitumor effect of T-96 was dependent on LRPPRC expression.
Takeaway
A compound from a Chinese herb can help fight lung cancer by stopping cancer cells from making energy in a specific way.
Methodology
The study used in vitro and in vivo experiments to assess the effects of T-96 on lung cancer cells, including assays for cell viability, apoptosis, and mitochondrial function.
Limitations
The study primarily focused on in vitro and animal models, which may not fully represent human responses.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website